Brain-fog reports tied to a new viral strain, overlooked autism signs in adults gain attention, and GLP-1 drugs are discussed for potential protective health effects.
Yale-led analysis of 4.5 million adults from 2013 to 2023 shows a sharp rise in self-reported cognitive difficulties, with the steepest growth among under-40s and minority and low-income groups.
Autopsy confirms degenerative brain disease linked to head trauma; shooter targeted NFL offices in a Park Avenue building; four people killed
Watermelon-flavored Good Gummies deliver 15 g protein and 11 g fiber per serving, but cost and flavor variety influence adoption.
Researchers link elevated TSPO levels to early brain inflammation in genetically at-risk models and in human tissue, hinting at a window for prevention.
State health officials say a Nassau County case is under review; officials stress that the public risk remains very low.
Vegan, sugar-free greens gummies tout 60 ingredients and third-party testing as celebrity fans join the trend; reviewers weigh taste, price and digestion claims.
Guidance outlines timing for adults, seniors, pregnant people and children, with vaccination encouraged by the end of October and continued through the season.
MgT may cross the blood-brain barrier and support cognitive function, but benefits unfold over weeks and aren’t guaranteed.